Skip to main content
LV

LuSeed Vascular

The startup develops a medical device specifically designed to treat bifurcating and side-wall aneurysms, reducing reliance on anticoagulants while providing enhanced metal coverage. This technology is particularly beneficial for managing ruptured cases, addressing the limitations of existing treatment options in neurovascular care.

Updated 2 months ago

Funding

$9.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current endovascular treatments for cerebral aneurysms demand significant physician expertise, can be lengthy, and often necessitate lifelong use of high-risk anticoagulants. There is a need for solutions that are easier to learn and implement, ensure long-term patient safety, and improve outcomes.

Solution

LuSeed Vascular offers the DOME™, a minimally invasive intrasaccular implant designed for the treatment of both bifurcation and sidewall brain aneurysms. The DOME™ features a dual-layered symmetric design that promotes continuous coverage of the aneurysm neck, ensuring intact wall apposition. Its design allows for implantation from various angles without unwanted protrusion into the parent artery, reducing the need for high-risk anticoagulants. The device's high mesh density facilitates acute diversion of pulsatile blood flow from the aneurysm sac, making it suitable for ruptured cases. The DOME™ is also designed for compatibility with robotic systems.

Target Audience

The primary users are neurointerventional physicians treating brain aneurysms, including both experienced specialists and those with less experience in complex endovascular procedures.

Features

  • Intrasaccular implant for treating both sidewall and bifurcation aneurysms
  • Dual-layered symmetric design for continuous aneurysm neck coverage and intact wall apposition
  • Delivery system allows for implantation from various angles
  • Minimal parent artery protrusion reduces the need for dual antiplatelet therapy (DAPT)
  • High mesh density promotes occlusion in ruptured cases
  • Designed for compatibility with robotic surgical systems
  • Available in five sizes for straightforward matching to aneurysm dimensions
This profile is AI-generated and may contain inaccuracies.